Abaxis Launches Quantitative Canine Lyme Disease Test



Published:

Abaxis Inc. added a quantitative antibody test for canine Lyme disease to its line of tests available through the Abaxis Veterinary Reference Laboratories Division in Olathe, Kan., the company reported today.

The test measures a combination of antibodies to peptides which mimic certain antigens of the Borrelia burgdorferi spirochete. The antibodies are not found in vaccinated or noninfected patients, allowing for a definitive diagnosis of the disease, according to Kenneth Aron, Ph.D., Abaxis' chief technology officer.

The test may be used as a standalone diagnostic test to determine infection status or efficacy during treatment. It also may be used as a quantitative confirmation test for Abaxis’ upcoming VetScan Lyme Rapid Test, which is under development, according to the Union City, Calif.-based company.

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Study Confirms Benefits of Pedicle Tie Spays

Compared to PDL, PT procedures are safe and reduce a patient’s anesthesia time.

Virbac Introduces Flea, Tick Killer EctoAdvance Plus

EctoAdvance Plus is a cost-effective alternative to FrontlinePlus, the manufacturer states.

Missouri Vet College to Hold Pet Memorial on May 2

The Companion Animal Memorial event is offered annually by the Together In Grief, Easing Recovery program to honor the lives of animals that have passed.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module